Assignee
BOLT BIOTHERAPEUTICS INC
US·6 granted patents·35 pending applications·2 citations·filing 2018–2025
Top patents by PatentIndex Score
41 records- 0190US11654199B2Thienoazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Granted May 23, 2023·2 cites·26 claims
- 0279US12325750B2Anti-Dectin-2 antibodies and methods of usingBOLT BIOTHERAPEUTICS INC·Filed 2023·Granted Jun 10, 2025·0 cites·29 claims
- 0373US11753474B2Anti-Dectin-2 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·131 claims
- 0473US2025270329A1Anti-Dectin-2 AntibodiesBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0571US2026034220A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0670US12465653B2Thienoazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2023·Granted Nov 11, 2025·0 cites·30 claims
- 0768US11400164B2Immunoconjugates targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 2, 2022·0 cites·44 claims
- 0866US2022347311A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0962US2020108151A1Antibody adjuvant conjugatesBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1061US2022195066A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1161US2025263392A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1260US2025127914A1Antibody-conjugated 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1358US2024197899A12-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1458US2025145575A1Macromolecule-supported 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1558US2024299569A12-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1657US2019015516A1Antibody adjuvant conjugatesBOLT BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1756US2025000995A1Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1855US2024417486A1Asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1955US2023263903A1Pyrazoloazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2054US2025057967A2Bis-benzimidazole sting agonist immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2153US2024033370A1Anti-pd-l1 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2253US2020390899A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2353US2024238430A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2452US2024042050A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2552US2023257393A1Macromolecule-supported thienoazepine compounds, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2652US2024091370A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2751US2023069055A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2851US2023165968A1Cancer treatment methodsBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2949US2023293716A1Elastase-substrate, peptide linker immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3049US2023086603A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3147US12570610B2Macromolecule-supported aminobenzazepine compoundsBOLT BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 10, 2026·0 cites·10 claims
- 3246US2022152215A1Immunoconjugates Targeting CEABOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3346US2022226492A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3446US2022347312A1Immunoconjugate Synthesis MethodBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3546US2022226491A1Immunoconjugates Targeting PD-L1BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3646US2022143012A1Macromolecule-Supported TLR AgonistsBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3746US2021187115A1Immunoconjugates Targeting EGFRBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3845US2021154316A1ImmunoconjugatesBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3945US2022313835A1Aminoquinoline compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4045US2022347310A1Amide-linked, aminobenzazepine immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4139US2021284750A1Immunoconjugate Synthesis MethodBOLT BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BOLT BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →